Understanding Your Genetic Risk for Inherited Neuropathy
If you or your family members experience unexplained muscle weakness, foot deformities, or sensory loss, you may be dealing with an inherited condition that affects thousands of South Africans. The PMP22 Gene CMT1A NGS Genetic DNA Test provides the clarity you need to understand your genetic health and make informed decisions about your future.
What This Test Reveals About Your Health
The PMP22 Gene CMT1A test examines your DNA for mutations in the PMP22 gene, which is responsible for producing a protein essential for proper nerve function. When this gene contains specific mutations, it can lead to Charcot-Marie-Tooth disease type 1A (CMT1A), an inherited peripheral neuropathy that affects the nerves controlling muscle movement and sensation.
Using advanced Next Generation Sequencing (NGS) technology, our test provides comprehensive analysis with exceptional accuracy, giving you reliable results you can trust for making important health decisions.
Who Should Consider This Genetic Test?
This test is particularly important if you experience:
- Progressive muscle weakness in feet, legs, hands, or arms
- High foot arches or hammer toes
- Decreased sensation to touch, heat, or cold
- Difficulty with balance and coordination
- Family history of similar neurological symptoms
- Unexplained tripping or frequent ankle sprains
If multiple family members show similar symptoms across generations, genetic testing becomes even more crucial for understanding inheritance patterns and planning for the future.
Why Early Detection Matters for Your Health Journey
Knowing your genetic status provides numerous benefits:
- Early Intervention: Identify conditions before severe symptoms develop
- Family Planning: Make informed decisions about having children
- Proper Management: Work with neurologists to develop appropriate care plans
- Peace of Mind: Reduce uncertainty about your genetic health
- Prevent Complications: Address symptoms early to maintain mobility and quality of life
Understanding Your Test Results
Our genetic counselling team will help you interpret your results with compassion and clarity:
- Positive Result: Indicates a PMP22 gene mutation associated with CMT1A. Our genetic counsellors will explain what this means for your health and provide guidance on next steps.
- Negative Result: No PMP22 mutation detected, significantly reducing the likelihood of CMT1A in you and potentially your children.
- Variant of Uncertain Significance: Rare cases where a genetic change is found but its significance is unknown. We provide ongoing monitoring as research evolves.
Regardless of your results, you’ll receive comprehensive support and guidance from our experienced healthcare professionals.
Affordable Genetic Testing for South African Families
| Service | Regular Price | Special Price | Savings |
|---|---|---|---|
| PMP22 Gene CMT1A NGS Genetic DNA Test | ZAR 9,350 | ZAR 6,700 | ZAR 2,650 |
Includes genetic counselling session and comprehensive result interpretation
Why Trust Oracle Genomics?
- Nationwide Coverage: Available in Johannesburg, Cape Town, Durban, Pretoria and across South Africa
- Expert Team: Working with qualified neurologists and genetic specialists
- Advanced Technology: Using Next Generation Sequencing for maximum accuracy
- Fast Turnaround: Results typically within 3-4 weeks
- Multiple Sample Options: Blood, extracted DNA, or blood spot on FTA card
- Comprehensive Preparation: Includes clinical history assessment and genetic counselling
Take Control of Your Genetic Health Today
Don’t let uncertainty about inherited conditions affect your quality of life. Early detection through genetic testing can provide the answers you need to plan for a healthier future.
Book your PMP22 Gene CMT1A test now and save ZAR 2,650 on our special pricing. Our team is ready to support you through every step of your genetic health journey.
Limited time special pricing available. Contact us today to secure your discounted test.
